These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8531129

  • 1. Participation of delta opioid receptor subtypes in the stimulation of adenylyl cyclase activity in rat olfactory bulb.
    Olianas MC, Onali P.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1560-7. PubMed ID: 8531129
    [Abstract] [Full Text] [Related]

  • 2. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
    Mattia A, Farmer SC, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Bowen WD, Porreca F.
    J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
    [Abstract] [Full Text] [Related]

  • 3. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
    Wild KD, Carlisi VJ, Mosberg HI, Bowen WD, Portoghese PS, Sultana M, Takemori AE, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 1993 Feb; 264(2):831-8. PubMed ID: 8382281
    [Abstract] [Full Text] [Related]

  • 4. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE, Hammond DL.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
    [Abstract] [Full Text] [Related]

  • 5. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR, Fleming LM, Selley DE, McNutt RW, Chang KJ.
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [Abstract] [Full Text] [Related]

  • 6. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors.
    Noble F, Cox BM.
    Brain Res; 1996 Apr 15; 716(1-2):107-17. PubMed ID: 8738226
    [Abstract] [Full Text] [Related]

  • 7. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH, Hogenboom F, Portoghese PS, Mulder AH, Schoffelmeer AN.
    J Pharmacol Exp Ther; 1989 Jun 15; 249(3):864-8. PubMed ID: 2543814
    [Abstract] [Full Text] [Related]

  • 8. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
    Vanderah T, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Hruby VJ, Haaseth RC, Matsunaga TO, Porreca F.
    Eur J Pharmacol; 1994 Feb 03; 252(2):133-7. PubMed ID: 8157053
    [Abstract] [Full Text] [Related]

  • 9. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat.
    Thorat SN, Hammond DL.
    J Pharmacol Exp Ther; 1997 Dec 03; 283(3):1185-92. PubMed ID: 9399992
    [Abstract] [Full Text] [Related]

  • 10. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
    Olianas MC, Onali P.
    Mol Pharmacol; 1992 Jul 03; 42(1):109-15. PubMed ID: 1321951
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL, Wang H, Nakashima N, Basbaum AI.
    J Pharmacol Exp Ther; 1998 Jan 03; 284(1):378-87. PubMed ID: 9435201
    [Abstract] [Full Text] [Related]

  • 12. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.
    Neuroscience; 2005 Jan 03; 135(1):213-25. PubMed ID: 16111831
    [Abstract] [Full Text] [Related]

  • 13. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
    Clark MJ, Emmerson PJ, Mansour A, Akil H, Woods JH, Portoghese PS, Remmers AE, Medzihradsky F.
    J Pharmacol Exp Ther; 1997 Nov 03; 283(2):501-10. PubMed ID: 9353363
    [Abstract] [Full Text] [Related]

  • 14. Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells.
    Belcheva MM, Barg J, Gloeckner C, Gao XM, Chuang DM, Coscia CJ.
    Mol Pharmacol; 1992 Sep 03; 42(3):445-52. PubMed ID: 1328845
    [Abstract] [Full Text] [Related]

  • 15. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC, Maullu C, Onali P.
    Br J Pharmacol; 1997 Oct 03; 122(3):401-8. PubMed ID: 9351494
    [Abstract] [Full Text] [Related]

  • 16. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
    Schoffelmeer AN, De Vries TJ, Hogenboom F, Mulder AH.
    J Pharmacol Exp Ther; 1993 Oct 03; 267(1):205-10. PubMed ID: 8229747
    [Abstract] [Full Text] [Related]

  • 17. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
    Horan PJ, Wild KD, Misicka A, Lipkowski A, Haaseth RC, Hruby VJ, Weber SJ, Davis TP, Yamamura HI, Porreca F.
    J Pharmacol Exp Ther; 1993 May 03; 265(2):896-902. PubMed ID: 8388462
    [Abstract] [Full Text] [Related]

  • 18. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
    Szekeres PG, Traynor JR.
    J Pharmacol Exp Ther; 1997 Dec 03; 283(3):1276-84. PubMed ID: 9400003
    [Abstract] [Full Text] [Related]

  • 19. Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. II. Characterization of the antagonist sensitivity and comparison with muscarinic inhibitions of the enzyme in striatum and heart.
    Olianas MC, Onali P.
    J Pharmacol Exp Ther; 1991 Nov 03; 259(2):680-6. PubMed ID: 1658307
    [Abstract] [Full Text] [Related]

  • 20. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice.
    Miyamoto Y, Bowen WD, Portoghese PS, Takemori AE.
    J Pharmacol Exp Ther; 1994 Jul 03; 270(1):37-9. PubMed ID: 8035333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.